Prediabetes Risk Doubled for Asian, Pacific Islander Teens With Overweight, Obesity
Findings show some variation by Asian subgroup
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
Patients With Diabetes More Likely to Experience Adverse Financial Outcomes
Authors say holistic treatment approaches may ease financial vulnerability for people with diabetes
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
Odds of incident T2D increased in association with each tertile increase in the PFAS mixture
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
AOMs linked to significant weight regain at eight weeks after drug discontinuation compared with control group
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users
FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods
The goal of the federally recognized definition is to provide consistency in research and policy to address health concerns associated with these foods
Endocrine Society, July 12-15
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
GLP-1 receptor agonist use linked to lower risk for overall dementia, Alzheimer disease, nonvascular dementia compared with metformin
